Literature DB >> 10194065

The potential role of chemokines and inflammatory cytokines in periodontal disease progression.

D T Graves1.   

Abstract

Inflammation is regulated by the expression of mediators that cause a number of pleiotropic events culminating in the recruitment of inflammatory cells and release of biologic mediators by leukocytes. If the inflammation is transient in nature, it can protect the host by activating defense mechanisms and initiating wound repair. However, if the inflammation is inappropriate, it can lead to considerable tissue damage. My colleagues and I have investigated the role of chemokines, particularly monocyte chemoattractant protein 1, in various pathological processes and the role of the proinflammatory cytokines interleukin-1 (IL-1) and tumor necrosis factor (TNF) in experimental periodontitis. I will discuss first the studies on chemokines and then the use of IL-1 and TNF blockers in inhibiting inflammation and bone loss in the periodontium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194065     DOI: 10.1086/515178

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  49 in total

1.  Long-term effect of heat shock protein 60 from Actinobacillus actinomycetemcomitans on epithelial cell viability and mitogen-activated protein kinases.

Authors:  Liangxuan Zhang; Steven Pelech; Veli-Jukka Uitto
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

2.  Tissue destruction induced by Porphyromonas gingivalis infection in a mouse chamber model is associated with host tumor necrosis factor generation.

Authors:  Yuh-Yih Lin; Jan-Hung Huang; Yo-Yin Lai; Han-Ching Huang; Suh-Woan Hu
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Soluble RANKL Cleaved from Activated Lymphocytes by TNF-α-Converting Enzyme Contributes to Osteoclastogenesis in Periodontitis.

Authors:  Hiroyuki Kanzaki; Seicho Makihira; Maiko Suzuki; Takenobu Ishii; Alexandru Movila; Josefine Hirschfeld; Hani Mawardi; Xiaoping Lin; Xiaozhe Han; Martin A Taubman; Toshihisa Kawai
Journal:  J Immunol       Date:  2016-10-07       Impact factor: 5.422

4.  Resolving Macrophages Counter Osteolysis by Anabolic Actions on Bone Cells.

Authors:  A Viniegra; H Goldberg; Ç Çil; N Fine; Z Sheikh; M Galli; M Freire; Y Wang; T E Van Dyke; M Glogauer; C Sima
Journal:  J Dent Res       Date:  2018-07-11       Impact factor: 6.116

5.  Identification, characterization, and isolation of a common progenitor for osteoclasts, macrophages, and dendritic cells from murine bone marrow and periphery.

Authors:  Christian E Jacome-Galarza; Sun-Kyeong Lee; Joseph A Lorenzo; Hector Leonardo Aguila
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

6.  CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease.

Authors:  Y Hosokawa; I Hosokawa; K Ozaki; H Nakae; K Murakami; Y Miyake; T Matsuo
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

7.  Effects of periodontal therapy on serum lipid profile and proinflammatory cytokines in patients with hyperlipidemia: a randomized controlled trial.

Authors:  Yong-Wei Fu; Xiang-Xin Li; Hong-Zhi Xu; Yong-Qing Gong; Yan Yang
Journal:  Clin Oral Investig       Date:  2015-10-05       Impact factor: 3.573

8.  Aural exostoses (surfer's ear) provide vital fossil evidence of an aquatic phase in Man's early evolution.

Authors:  P H Rhys Evans; M Cameron
Journal:  Ann R Coll Surg Engl       Date:  2017-09-15       Impact factor: 1.891

9.  Relationships among interleukin-6, tumor necrosis factor-α, adipokines, vitamin D, and chronic periodontitis.

Authors:  Flavia R Teles; Ricardo P Teles; Lynn Martin; Sigmund S Socransky; Anne D Haffajee
Journal:  J Periodontol       Date:  2011-12-19       Impact factor: 6.993

Review 10.  The potential of p38 MAPK inhibitors to modulate periodontal infections.

Authors:  Keith L Kirkwood; Carlos Rossa
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.